Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Marapharm Ventures

Marapharm Ventures
2007 FOUNDED
PUBLIC STATUS
MDM STOCK SYMBOL
6 INVESTMENTS
$0.26 SHARE PRICE (As of Wednesday Closing)
Description

Operator of an investment company aimed at the medical and recreational marijuana markets. The company's services include production of medical cannabis on the tribal lands with respect for the environment in all natural soil with proper amendments and pest control management, enabling pharmaceutical companies to use marijuana for medical purpose. It alos offers research, development and investment services.

Formerly Known As
Capital Auction Market
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Capital Markets/Institutions
Other Industries
Pharmaceuticals
Stock Exchange
CNQ
Primary Office
  • 102 - 1561 Sutherland Avenue
  • Kelowna, British Columbia V1Y 5Y7
  • Canada

+1 (778) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Marapharm Ventures’s full profile, request a free trial.

Marapharm Ventures Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.26 - $1.04 $25.9M $0.28 -$0.15 601K 93.8M

Marapharm Ventures Financials Summary

In Thousands,
USD
TTM
30-Sep-2017
FY 2017
31-Mar-2017
FY 2016
31-Mar-2016
FY 2015
31-Mar-2015
Enterprise Value 59,506 64,825 7,374
Revenue 335 292 0
EBITDA (9,394) (7,358) (2,495) (4,066)
Net Income (9,803) (7,606) (2,508) (4,067)
Total Assets 13,890 9,475 899 942
Total Debt 1,006 966 303 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Marapharm Ventures Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Marapharm Ventures‘s full profile, request access.

Request full access to PitchBook

Marapharm Ventures Investments & Acquisitions (6)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000000 29-Mar-2018 0000 00.000 Drug Discovery
000000000 00000000 14-Feb-2018 000000000000000000 00.00 Cultivation 00000 0000000
00000000 000000000 27-Sep-2017 000000000 00000 00 00000 Buildings and Property 00000 0000000
00000000000000 18-Feb-2017 000000000000000000 00000 Logistics 00000 0000000
Industrial property (7 acres) 19-Dec-2016 Corporate Asset Purchase Buildings and Property 00000 0000000
To view this company’s complete investment and acquisition history, request access »

Marapharm Ventures Executive Team (5)

Name Title Board
Seat
Contact
Info
Linda Sampson Chief Executive Officer, President & Director
Hanspaul Pannu Chief Financial Officer
Corey Klassen Vice President, Corporate Development & Director
Ron Cannan Advisor, Management Advisory Group

1 Former Executive

You’re viewing 4 of 5 executives. Get the full list »